ClinicalTrials.gov
ClinicalTrials.gov Menu

Autism Registry for French Guiana (REGUYAUT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02903732
Recruitment Status : Recruiting
First Posted : September 16, 2016
Last Update Posted : September 16, 2016
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier de Cayenne

Brief Summary:
The objective of the autism registry is to estimate the prevalence of autism in French Guiana in the cohort of children aged 8 years. Secondary objectives are to determine the prevalence of comorbidities, and to determine the theoretical and actual orientation of these children regarding care and education in a territory with significant structural deficits relative to mainland France. The outcomes of this registry will be to guide decision makers in their funding priorities to improve, screening, diagnosis, care and education for children on the autistic spectrum

Condition or disease Intervention/treatment
Autism Spectrum Disorder Other: observational

Study Type : Observational [Patient Registry]
Estimated Enrollment : 400 participants
Time Perspective: Cross-Sectional
Target Follow-Up Duration: 10 Years
Official Title: Autism Registry for French Guiana
Study Start Date : September 2015
Actual Primary Completion Date : September 2015
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Intervention Details:
    Other: observational
    registry


Primary Outcome Measures :
  1. autism spectrum disorder [ Time Frame: 1 year (the year at age 8) ]
    the number of 8 year old children with a diagnosis of autism spectrum disorder in a given year relative to the total population of children aged 8 years old in that given year



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   8 Years to 8 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
children aged 8 years will be the denominator. the numerator is children who are seeking assistance for care or educational purposes at the unique administration dealing with handicap in French Guiana
Criteria

Inclusion Criteria:

  • children aged 8 years with a diagnosis of autism spectrum disorder

Exclusion Criteria:

  • refusal to participate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02903732


Locations
France
Centre Hospitalier de Cayenne Recruiting
Cayenne, French Guiana, France, 97306
Contact: Mathieu Nacher, MD, PhD    0594395024 ext 5024    mathieu.nacher@ch-cayenne.fr   
Sponsors and Collaborators
Centre Hospitalier de Cayenne

Responsible Party: Centre Hospitalier de Cayenne
ClinicalTrials.gov Identifier: NCT02903732     History of Changes
Other Study ID Numbers: REGUYAUT
First Posted: September 16, 2016    Key Record Dates
Last Update Posted: September 16, 2016
Last Verified: September 2016

Additional relevant MeSH terms:
Autistic Disorder
Autism Spectrum Disorder
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders